1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Dankook University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Shortening of MDR-TB Using Existing and New Drugs Linezolid, Delamanid, Levofloxacin - Tuberculosis, Multidrug-Resistant | Phase 2 | Completed | Seoul National University Hospital | 214 | 2016-01-01 | 2025-01-03 |
Tuberculosis, Multidrug-Resistant (1)
Levofloxacin (1) · Linezolid (1) · OPC-67683 (1) · Pyrazinamide (1)
South Korea (1)